Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIOW) EBIT Margin (2022 - 2025)

Historic EBIT Margin for Cardio Diagnostics Holdings (CDIOW) over the last 4 years, with Q3 2025 value amounting to 59950.86%.

  • Cardio Diagnostics Holdings' EBIT Margin fell 385379900.0% to 59950.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 41422.24%, marking a year-over-year decrease of 179088100.0%. This contributed to the annual value of 23977.86% for FY2024, which is 184625600.0% up from last year.
  • Latest data reveals that Cardio Diagnostics Holdings reported EBIT Margin of 59950.86% as of Q3 2025, which was down 385379900.0% from 22457.51% recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' EBIT Margin registered a high of 14398.71% during Q3 2023, and its lowest value of 250321.79% during Q4 2022.
  • For the 4-year period, Cardio Diagnostics Holdings' EBIT Margin averaged around 72278.39%, with its median value being 29039.51% (2023).
  • Its EBIT Margin has fluctuated over the past 5 years, first skyrocketed by 2000000000bps in 2023, then crashed by -1473585600bps in 2025.
  • Cardio Diagnostics Holdings' EBIT Margin (Quarter) stood at 250321.79% in 2022, then skyrocketed by 88bps to 29039.51% in 2023, then decreased by -16bps to 33608.2% in 2024, then tumbled by -78bps to 59950.86% in 2025.
  • Its last three reported values are 59950.86% in Q3 2025, 22457.51% for Q2 2025, and 173463.83% during Q1 2025.